Kent County Memorial Hospital: drugs

Schedule G of this filing lists 387 drugs, with an amount and a number of claims for each, as filed. Every amount links to its page of the filing.

The schedule's total is printed as “Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement”. The filings describe the amounts in more than one way. Methods says more.

All 387 drug rows

Schedule G as filed, for Kent County Memorial Hospital: 387 drugs, in the order filed
LineDrugAmount as filedClaims as filed
1Kesimpta 20 mg/0.4 mL pen00078100768Listed by the FDA as Kesimptaofatumumab20 mg/0.4 mLinjection, solutionNovartis Pharmaceuticals Corporation1,933,416.47 (Schedule G, line 1, page 10 of the filing PDF)276
2pembrolizumab 100 mg/4 mL INJ00006302602Listed by the FDA as Keytrudapembrolizumab25 mg/mLinjection, solutionMerck Sharp & Dohme LLC1,559,990.40 (Schedule G, line 2, page 10 of the filing PDF)171
3daratumumab-hyaluronidase 1,800 mg-30,000 units INJ 15 mL78940503011,240,777.54 (Schedule G, line 3, page 10 of the filing PDF)206
4Brukinsa 80 mg capsule72579001102Listed by the FDA as Brukinsazanubrutinib80 mgcapsuleBeOne Medicines USA, Inc.1,181,074.04 (Schedule G, line 4, page 10 of the filing PDF)128
5Dupixent 300 mg/2 mL pen00024591502Listed by the FDA as Dupixentdupilumab300 mg/2 mLinjection, solutionSanofi-Aventis U.S. LLC1,168,095.81 (Schedule G, line 5, page 10 of the filing PDF)171
6Tagrisso 80 mg tablet00310135030Listed by the FDA as Tagrissoosimertinib80 mgtablet, film coatedAstraZeneca Pharmaceuticals LP1,119,735.99 (Schedule G, line 6, page 10 of the filing PDF)91
7Ofev 150 mg capsule00597014560Listed by the FDA as Ofevnintedanib150 mgcapsuleBoehringer Ingelheim Pharmaceuticals, Inc.996,080.90 (Schedule G, line 7, page 10 of the filing PDF)112
8Calquence 100 mg tablet00310351260Listed by the FDA as Calquenceacalabrutinib100 mgtablet, film coatedAstraZeneca Pharmaceuticals LP958,829.00 (Schedule G, line 8, page 10 of the filing PDF)103
9MPB Opdivo 240 mg/24 mL SDV00003373413Listed by the FDA as Opdivonivolumab10 mg/mLinjectionE.R. Squibb & Sons, L.L.C.866,349.21 (Schedule G, line 9, page 10 of the filing PDF)154
10Nubeqa 300 mg tablet50419039501Listed by the FDA as Nubeqadarolutamide300 mgtablet, film coatedBayer HealthCare Pharmaceuticals Inc.693,979.05 (Schedule G, line 10, page 10 of the filing PDF)88
11Humira(CF) pen 40 mg/0.4 mL00074055402Listed by the FDA as HumiraadalimumabkitAbbVie Inc.631,773.90 (Schedule G, line 11, page 10 of the filing PDF)376
12Nucala 100 mg/mL auto-injector00173089201Listed by the FDA as Nucalamepolizumab100 mg/mLinjection, solutionGlaxoSmithKline LLC605,715.89 (Schedule G, line 12, page 10 of the filing PDF)87
13ivosidenib 250 mg Tab72694061760Listed by the FDA as Tibsovoivosidenib250 mgtablet, film coatedServier Pharmaceutical LLC592,600.36 (Schedule G, line 13, page 10 of the filing PDF)26
14venetoclax (Venclexta) 100 mg Tab00074057622Listed by the FDA as Venclextavenetoclax100 mgtablet, film coatedAbbVie Inc.559,576.98 (Schedule G, line 14, page 10 of the filing PDF)95
15Verzenio 100 mg tablet00002481554Listed by the FDA as Verzenioabemaciclib100 mgtabletEli Lilly and Company535,284.40 (Schedule G, line 15, page 10 of the filing PDF)9
16Skyrizi 150 mg/mL pen00074210001Listed by the FDA as Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc.528,240.25 (Schedule G, line 16, page 10 of the filing PDF)32
17tafamidis 61 mg cap00069873030Listed by the FDA as Vyndamaxtafamidis61 mgcapsule, liquid filledPfizer Laboratories Div Pfizer Inc525,724.66 (Schedule G, line 17, page 10 of the filing PDF)31
18palbociclib (Ibrance) 75 mg Tab00069028403Listed by the FDA as Ibrancepalbociclib75 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc503,801.00 (Schedule G, line 18, page 10 of the filing PDF)56
19ravulizumab-cwvz 300 mg/3 mL INJ25682002501Listed by the FDA as Ultomirisravulizumab300 mg/3 mLsolution, concentrateAlexion Pharmaceuticals Inc.475,610.73 (Schedule G, line 19, page 10 of the filing PDF)10
20durvalumab (Imfinzi) 1,500 mg in sodium chloride 0.9% 250 mL IVPB00310461150Listed by the FDA as Imfinzidurvalumab500 mg/10 mLinjection, solutionAstraZeneca Pharmaceuticals LP466,661.08 (Schedule G, line 20, page 11 of the filing PDF)72
21Ofev 100 mg capsule00597014360Listed by the FDA as Ofevnintedanib100 mgcapsuleBoehringer Ingelheim Pharmaceuticals, Inc.462,673.60 (Schedule G, line 21, page 11 of the filing PDF)54
22teprotumumab (Tepezza) 500 mg injection75987013015Listed by the FDA as Tepezzateprotumumab500 mginjection, powder, lyophilized, for solutionHorizon Therapeutics USA, Inc.421,049.28 (Schedule G, line 22, page 11 of the filing PDF)8
23Mounjaro 5 mg/0.5 mL pen00002149580Listed by the FDA as Mounjarotirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company408,777.81 (Schedule G, line 23, page 11 of the filing PDF)42
24talquetamab tgvs 40 mg/mL INJ57894047001Listed by the FDA as Talveytalquetamab-tgvs40 mg/mLinjectionJanssen Biotech, Inc.388,414.12 (Schedule G, line 24, page 11 of the filing PDF)49
25Verzenio 150 mg tablet00002533754Listed by the FDA as Verzenioabemaciclib150 mgtabletEli Lilly and Company368,827.48 (Schedule G, line 25, page 11 of the filing PDF)10
26MPB Tezspire 210 mg/1.91 mL pen55513012301Listed by the FDA as Tezspiretezepelumab-ekko210 mg/1.9 mLinjection, solutionAmgen Inc335,617.81 (Schedule G, line 26, page 11 of the filing PDF)121
27Privigen 40 g/400 mL SOLN44206043940Listed by the FDA as Privigenhuman immunoglobulin G40 g/400 mLliquidCSL Behring AG328,335.70 (Schedule G, line 27, page 11 of the filing PDF)148
28Cosentyx Snrdy 300 mg dose-2pen00078063941Listed by the FDA as Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation307,517.32 (Schedule G, line 28, page 11 of the filing PDF)43
29Fasenra pen 30 mg/mL00310183030Listed by the FDA as Fasenrabenralizumab30 mg/mLinjection, solutionAstraZeneca Pharmaceuticals LP288,508.19 (Schedule G, line 29, page 11 of the filing PDF)76
30Kcentra 1,000 units KIT63833038702Listed by the FDA as Kcentraprothrombin, coagulation factor VII human, coagulation factor IX human, coagulation factor X human, protein C, protein S human, and waterkitCSL Behring GmbH285,916.19 (Schedule G, line 30, page 11 of the filing PDF)82
31Ibrance tab 125 mg00069068803Listed by the FDA as Ibrancepalbociclib125 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc279,800.77 (Schedule G, line 31, page 11 of the filing PDF)30
32Erbitux VL 2 mg/mL 100 mL66733095823Listed by the FDA as Erbituxcetuximab2 mg/mLsolutionImClone LLC279,398.77 (Schedule G, line 32, page 11 of the filing PDF)280
33Xtandi 40 mg tablet00469062599Listed by the FDA as Xtandienzalutamide40 mgtabletAstellas Pharma US, Inc.270,850.49 (Schedule G, line 33, page 11 of the filing PDF)50
34Skyrizi 360 mg/2.4 mL on-body00074107001Listed by the FDA as Skyrizirisankizumab-rzaakitAbbVie Inc.266,341.39 (Schedule G, line 34, page 11 of the filing PDF)27
35MPB Erleada 60 mg tab 12059676060012Listed by the FDA as Erleadaapalutamide60 mgtablet, film coatedJanssen Products, LP259,454.97 (Schedule G, line 35, page 11 of the filing PDF)26
36Privigen 20 g/200 mL SOLN44206043820Listed by the FDA as Privigenhuman immunoglobulin G20 g/200 mLliquidCSL Behring AG250,477.15 (Schedule G, line 36, page 11 of the filing PDF)220
37MPB Gazyva inj 1,000 mg/40 mL inj50242007001Listed by the FDA as Gazyvaobinutuzumab1,000 mg/40 mLinjection, solution, concentrateGenentech, Inc.246,600.69 (Schedule G, line 37, page 11 of the filing PDF)47
38MPB Tavalisse 100 mg tab 6071332000101Listed by the FDA as Tavalissefostamatinib100 mgtabletRigel Pharmaceuticals, Inc.239,946.48 (Schedule G, line 38, page 11 of the filing PDF)29
39Stelara PFS 90 mg/1.0 mL 157894006103Listed by the FDA as Stelaraustekinumab90 mg/mLinjection, solutionJanssen Biotech, Inc.239,671.99 (Schedule G, line 39, page 11 of the filing PDF)29
40Mekinist tab 2 mg00078111215Listed by the FDA as Mekinisttrametinib2 mgtablet, film coatedNovartis Pharmaceuticals Corporation238,145.26 (Schedule G, line 40, page 11 of the filing PDF)14
41Taltz 80 mg/mL autoinjector00002144511Listed by the FDA as Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company237,833.62 (Schedule G, line 41, page 11 of the filing PDF)32
42Tafinlar 75 mg capsule00078068166Listed by the FDA as Tafinlardabrafenib75 mgcapsuleNovartis Pharmaceuticals Corporation234,586.59 (Schedule G, line 42, page 11 of the filing PDF)14
43Kisqali 600 mg Daily dose00078087463Listed by the FDA as Kisqaliribociclib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation229,674.19 (Schedule G, line 43, page 11 of the filing PDF)12
44Ozempic 0.25-0.5 mg/dose pen00169418113Listed by the FDA as Ozempicsemaglutide0.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP226,875.28 (Schedule G, line 44, page 11 of the filing PDF)701
45Mounjaro 7.5 mg/0.5 mL pen00002148480Listed by the FDA as Mounjarotirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company222,565.78 (Schedule G, line 45, page 11 of the filing PDF)18
46Ozempic 2 mg/dose (8 mg/3 mL)00169477212Listed by the FDA as Ozempicsemaglutide2.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP220,425.00 (Schedule G, line 46, page 11 of the filing PDF)820
47Mounjaro 2.5 mg/0.5 mL pen00002150680Listed by the FDA as Mounjarotirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company217,002.22 (Schedule G, line 47, page 11 of the filing PDF)15
48MPB Tecentriq 1,200 mg/20 mL SDV50242091701Listed by the FDA as Tecentriqatezolizumab1,200 mg/20 mLinjection, solutionGenentech, Inc.207,753.69 (Schedule G, line 48, page 11 of the filing PDF)27
49asciminib (Scemblix) 40 mg Tab00078109820Listed by the FDA as Scemblixasciminib40 mgtablet, film coatedNovartis Pharmaceuticals Corporation206,269.52 (Schedule G, line 49, page 11 of the filing PDF)20
50Mounjaro 10 mg/0.5 mL pen00002147180Listed by the FDA as Mounjarotirzepatide10 mg/0.5 mLinjection, solutionEli Lilly and Company205,173.97 (Schedule G, line 50, page 11 of the filing PDF)23
51Ozempic 1 mg/dose (4 mg/3 mL)00169413013Listed by the FDA as Ozempicsemaglutide1.34 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP202,809.95 (Schedule G, line 51, page 11 of the filing PDF)562
52MPB Lonsurf 20 mg/8.19 mg tab 6064842102003Listed by the FDA as Lonsurftrifluridine and tipiracil20 mg; 8.19 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd.200,790.95 (Schedule G, line 52, page 11 of the filing PDF)19
53MPB Tepmetko 225 mg tab 30 DS44087500003Listed by the FDA as Tepmetkotepotinib hydrochloride225 mgtabletEMD Serono, Inc.198,564.10 (Schedule G, line 53, page 11 of the filing PDF)21
54Verzenio 50 mg tablet00002448354Listed by the FDA as Verzenioabemaciclib50 mgtabletEli Lilly and Company197,159.48 (Schedule G, line 54, page 11 of the filing PDF)fewer than 6 (the count is not shown)
55MPB Jakafi 10 mg tab 6050881001060Listed by the FDA as Jakafiruxolitinib10 mgtabletIncyte Corporation196,312.46 (Schedule G, line 55, page 11 of the filing PDF)34
56Actemra ACTPen inj 162 mg/0.9 mL50242014301Listed by the FDA as Actemra ACTPentocilizumab162 mg/0.9 mLinjection, solutionGenentech, Inc.196,287.78 (Schedule G, line 56, page 11 of the filing PDF)100
57canakinumab (Ilaris, PF,) 150 mg/mL Soln00078073461Listed by the FDA as Ilariscanakinumab150 mg/mLinjection, solutionNovartis Pharmaceuticals Corporation194,196.84 (Schedule G, line 57, page 11 of the filing PDF)14
58Repatha 140 mg/mL Sureclick 2CT72511076002Listed by the FDA as Repathaevolocumab140 mg/mLinjection, solutionAmgen USA Inc.192,265.18 (Schedule G, line 58, page 12 of the filing PDF)1,118
59Bridion 200 mg/2 mL SOLN00006542312Listed by the FDA as Bridionsugammadex100 mg/mLinjection, solutionMerck Sharp & Dohme LLC192,125.48 (Schedule G, line 59, page 12 of the filing PDF)2,269
60MPB Sarclisa 500 mg/25 mL SDV00024065601Listed by the FDA as Sarclisaisatuximab500 mg/25 mLinjection, solution, concentrateSanofi-Aventis U.S. LLC188,067.09 (Schedule G, line 60, page 12 of the filing PDF)65
61Gammagard liquid 10% vial00944270007Listed by the FDA as Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc.186,216.80 (Schedule G, line 61, page 12 of the filing PDF)119
62osimertinib (Tagrisso) 40 mg Tab00310134930Listed by the FDA as Tagrissoosimertinib40 mgtablet, film coatedAstraZeneca Pharmaceuticals LP180,379.65 (Schedule G, line 62, page 12 of the filing PDF)14
63MPB Reblozyl 75 mg SDV59572077501Listed by the FDA as Reblozylluspatercept75 mginjection, powder, lyophilized, for solutionCelgene Corporation170,509.02 (Schedule G, line 63, page 12 of the filing PDF)19
64glecaprevir-pibrentasvir (Mavyret) 100-40 mg Tab00074262528Listed by the FDA as Mavyretglecaprevir and pibrentasvir40 mg; 100 mgtablet, film coatedAbbVie Inc.169,321.81 (Schedule G, line 64, page 12 of the filing PDF)9
65Mounjaro 15 mg/0.5 mL pen00002145780Listed by the FDA as Mounjarotirzepatide15 mg/0.5 mLinjection, solutionEli Lilly and Company168,293.50 (Schedule G, line 65, page 12 of the filing PDF)10
66Kevzara inj PFP200 mg/1.14 mL 200024592201Listed by the FDA as Kevzarasarilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC166,932.87 (Schedule G, line 66, page 12 of the filing PDF)88
67Trelegy Ellipta 200-62.5-2500173089310Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate200 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC163,642.98 (Schedule G, line 67, page 12 of the filing PDF)675
68MPB Imbruvica 420 mg tab 2857962042028Listed by the FDA as Imbruvicaibrutinib420 mgtablet, film coatedPharmacyclics LLC154,896.66 (Schedule G, line 68, page 12 of the filing PDF)24
69MPB Jakafi 20 mg tab 6050881002060Listed by the FDA as Jakafiruxolitinib20 mgtabletIncyte Corporation150,533.78 (Schedule G, line 69, page 12 of the filing PDF)26
70midostaurin (Rydapt) 25 mg cap00078069819Listed by the FDA as Rydapt25 mgcapsule, liquid filledNovartis Pharmaceuticals Corporation149,632.24 (Schedule G, line 70, page 12 of the filing PDF)6
71Ibrance 100 mg tablet00069048603Listed by the FDA as Ibrancepalbociclib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc149,033.77 (Schedule G, line 71, page 12 of the filing PDF)18
72enzalutamide 40 mg cap00469012599Listed by the FDA as Xtandienzalutamide40 mgcapsuleAstellas Pharma US, Inc.148,991.78 (Schedule G, line 72, page 12 of the filing PDF)13
73nilotinib HCl 150 mg cap00078059287Listed by the FDA as Tasignanilotinib150 mgcapsuleNovartis Pharmaceuticals Corporation148,606.03 (Schedule G, line 73, page 12 of the filing PDF)26
74Rinvoq ER 15 mg tablet00074230630Listed by the FDA as Rinvoqupadacitinib15 mgtablet, extended releaseAbbVie Inc.141,029.85 (Schedule G, line 74, page 12 of the filing PDF)52
75MPB Doptelet 20 mg tab 1571369002015Listed by the FDA as Dopteletavatrombopag maleate20 mgtablet, film coatedAkaRx, Inc.140,431.86 (Schedule G, line 75, page 12 of the filing PDF)37
76MPB Vonjo 100 mg cap 12072482010012Listed by the FDA as Vonjopacritinib100 mgcapsuleSobi, Inc.137,892.12 (Schedule G, line 76, page 12 of the filing PDF)9
77cabazitaxel 60 mg/6 mL INJ00024582411Listed by the FDA as JevtanacabazitaxelkitSanofi-Aventis U.S. LLC135,477.92 (Schedule G, line 77, page 12 of the filing PDF)23
78MPB Lonsurf 15 mg/6.14 mg tab 6064842102503Listed by the FDA as Lonsurftrifluridine and tipiracil15 mg; 6.14 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd.134,817.20 (Schedule G, line 78, page 12 of the filing PDF)17
79iron dextran 100 mg/2 mL INJ00023608210Listed by the FDA as INFeDiron dextran50 mg/mLinjectionAllergan, Inc.133,832.32 (Schedule G, line 79, page 12 of the filing PDF)358
80MPB Brukinsa 160 mg tab 6072579012201Listed by the FDA as Brukinsazanubrutinib160 mgtablet, film coatedBeOne Medicines USA, Inc.133,178.54 (Schedule G, line 80, page 12 of the filing PDF)11
81Trelegy Ellipta 100-62.5-2500173088710Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate100 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC128,672.64 (Schedule G, line 81, page 12 of the filing PDF)789
82ribociclib (Kisqali) 400 mg/day (200 mg x 2) Tab00078086742Listed by the FDA as Kisqaliribociclib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation127,830.02 (Schedule G, line 82, page 12 of the filing PDF)16
83Hadlima PSH inj 40 mg/0.4 mL 2PK78206018701Listed by the FDA as Hadlimaadalimumab-bwwd40 mg/0.4 mLsolutionOrganon LLC127,026.66 (Schedule G, line 83, page 12 of the filing PDF)218
84MPB Kyprolis 60 mg inj pwd76075010101Listed by the FDA as Kyproliscarfilzomib60 mg/30 mLinjection, powder, lyophilized, for solutionOnyx Pharmaceuticals, Inc.126,559.70 (Schedule G, line 84, page 12 of the filing PDF)82
85Nplate 500 mcg SOLR55513022201Listed by the FDA as Nplateromiplostim500 mcg/mLinjection, powder, lyophilized, for solutionAmgen, Inc122,752.37 (Schedule G, line 85, page 12 of the filing PDF)148
86MPB Lenvima 18 mg BPK cap 9062856071830Listed by the FDA as LenvimalenvatinibkitEisai Inc.120,481.41 (Schedule G, line 86, page 12 of the filing PDF)11
87Repatha LF inj 140 mg 1 mL 272511039302Listed by the FDA as Repathaevolocumab140 mg/mLinjection, solutionAmgen USA Inc.119,366.36 (Schedule G, line 87, page 12 of the filing PDF)697
88MPB Enhertu 100 mg SDV65597040601Listed by the FDA as Enhertufam-trastuzumab deruxtecan-nxki100 mg/5 mLinjection, powder, lyophilized, for solutionDaiichi Sankyo Inc.117,375.84 (Schedule G, line 88, page 12 of the filing PDF)56
89Xgeva SDV 120 mg/1.7 mL 155513073001Listed by the FDA as Xgevadenosumab120 mg/1.7 mLinjectionAmgen, Inc116,922.90 (Schedule G, line 89, page 12 of the filing PDF)78
90MPB Polivy 30 mg SDV50242010301Listed by the FDA as Polivypolatuzumab vedotin30 mg/1.88 mLinjection, powder, lyophilized, for solutionGenentech, Inc.116,002.13 (Schedule G, line 90, page 12 of the filing PDF)40
91Trulicity 3 mg/0.5 mL pen00002223680Listed by the FDA as Trulicitydulaglutide3 mg/0.5 mLinjection, solutionEli Lilly and Company113,433.21 (Schedule G, line 91, page 12 of the filing PDF)6
92MPB Yervoy 50 mg/10 mL SDV00003232711Listed by the FDA as Yervoyipilimumab5 mg/mLinjectionE.R. Squibb & Sons, L.L.C.112,974.18 (Schedule G, line 92, page 12 of the filing PDF)18
93Dupixent PFS300 mg/2 mL 200024591401Listed by the FDA as Dupixentdupilumab300 mg/2 mLinjection, solutionSanofi-Aventis U.S. LLC109,947.01 (Schedule G, line 93, page 12 of the filing PDF)50
94Zepbound 5 mg/0.5 mL pen00002249580Listed by the FDA as Zepboundtirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company109,749.40 (Schedule G, line 94, page 12 of the filing PDF)fewer than 6 (the count is not shown)
95MPB Lazcluze 80 mg tab 6057894008060Listed by the FDA as Lazcluzelazertinib80 mgtablet, film coatedJanssen Biotech, Inc.109,267.39 (Schedule G, line 95, page 12 of the filing PDF)8
96capmatinib 200 mg Tab00078071656Listed by the FDA as Tabrectacapmatinib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation107,217.18 (Schedule G, line 96, page 13 of the filing PDF)7
97MPB Sarclisa 100 mg/5 mL SDV00024065401Listed by the FDA as Sarclisaisatuximab100 mg/5 mLinjection, solution, concentrateSanofi-Aventis U.S. LLC103,855.34 (Schedule G, line 97, page 13 of the filing PDF)180
98BESREMi 500 mcg/mL syringe73536050001Listed by the FDA as BESREMiropeginterferon alfa-2b500 mcg/mLinjectionPharmaEssentia USA103,686.65 (Schedule G, line 98, page 13 of the filing PDF)37
99momelotinib (Ojjaara) 100 mg Tab81864010330Listed by the FDA as Ojjaaramomelotinib100 mgtabletGlaxoSmithKline LLC103,634.09 (Schedule G, line 99, page 13 of the filing PDF)fewer than 6 (the count is not shown)
100Eliquis 5 mg tablet00003089421Listed by the FDA as Eliquisapixaban5 mgtablet, film coatedE.R. Squibb & Sons, L.L.C.103,028.64 (Schedule G, line 100, page 13 of the filing PDF)2,377
101Zepbound 2.5 mg/0.5 mL inj (4PF pens)00002250680Listed by the FDA as Zepboundtirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company100,133.22 (Schedule G, line 101, page 13 of the filing PDF)fewer than 6 (the count is not shown)
102Trulicity 4.5 mg/0.5 mL pen00002318280Listed by the FDA as Trulicitydulaglutide4.5 mg/0.5 mLinjection, solutionEli Lilly and Company99,808.57 (Schedule G, line 102, page 13 of the filing PDF)fewer than 6 (the count is not shown)
103Ruxience 500 mg/50 mL SOLN00069024901Listed by the FDA as Ruxiencerituximab-pvvr500 mg/50 mLinjection, solutionPfizer Laboratories Div Pfizer Inc99,734.08 (Schedule G, line 103, page 13 of the filing PDF)224
104MPB Jaypirca 100 mg tab 6000002702660Listed by the FDA as Jaypircapirtobrutinib100 mgtablet, coatedEli Lilly and Company99,586.02 (Schedule G, line 104, page 13 of the filing PDF)6
105Privigen 10 g/100 mL SOLN44206043710Listed by the FDA as Privigenhuman immunoglobulin G10 g/100 mLliquidCSL Behring AG97,655.46 (Schedule G, line 105, page 13 of the filing PDF)160
106MPB Benlysta SC pen 200 mg/mL 449401008835Listed by the FDA as Benlystabelimumab200 mg/mLsolutionGlaxoSmithKline LLC96,918.95 (Schedule G, line 106, page 13 of the filing PDF)29
107Botox 200 units SOLR00023392102Listed by the FDA as BotoxonabotulinumtoxinA200 USP unitsinjection, powder, lyophilized, for solutionAllergan, Inc.95,408.07 (Schedule G, line 107, page 13 of the filing PDF)fewer than 6 (the count is not shown)
108Dupixent 200 mg/1.14 mL pen00024591902Listed by the FDA as Dupixentdupilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC95,245.85 (Schedule G, line 108, page 13 of the filing PDF)15
109Teriparatide inj 250 mcg/mL 147781065289Listed by the FDA as Teriparatide250 mcg/mLinjection, solutionAlvogen, Inc.92,833.00 (Schedule G, line 109, page 13 of the filing PDF)25
110immune globulin (Gammagard) IV 10% 20 g/200 mL00944270006Listed by the FDA as Gammagard Liquidimmune globulin infusion (human)100 mg/mLinjection, solutionTakeda Pharmaceuticals America, Inc.91,936.40 (Schedule G, line 110, page 13 of the filing PDF)60
111MPB Tavalisse 150 mg tab 6071332000201Listed by the FDA as Tavalissefostamatinib150 mgtabletRigel Pharmaceuticals, Inc.91,402.43 (Schedule G, line 111, page 13 of the filing PDF)11
112Mounjaro 12.5 mg/0.5 mL pen00002146080Listed by the FDA as Mounjarotirzepatide12.5 mg/0.5 mLinjection, solutionEli Lilly and Company90,438.58 (Schedule G, line 112, page 13 of the filing PDF)6
113MPB Imbruvica 140 mg cap 90S57962014009Listed by the FDA as Imbruvicaibrutinib140 mgcapsulePharmacyclics LLC90,138.54 (Schedule G, line 113, page 13 of the filing PDF)13
114Pomalyst 3 mg capsule59572050321Listed by the FDA as Pomalystpomalidomide3 mgcapsuleCelgene Corporation89,061.64 (Schedule G, line 114, page 13 of the filing PDF)10
115Nucala inj 100 mg/mL00173089242Listed by the FDA as Nucalamepolizumab100 mg/mLinjection, solutionGlaxoSmithKline LLC88,510.68 (Schedule G, line 115, page 13 of the filing PDF)fewer than 6 (the count is not shown)
116Rinvoq ER 30 mg tablet00074231030Listed by the FDA as Rinvoqupadacitinib30 mgtablet, extended releaseAbbVie Inc.88,166.23 (Schedule G, line 116, page 13 of the filing PDF)35
117Tremfya 100 mg 157894064011Listed by the FDA as Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc.81,635.98 (Schedule G, line 117, page 13 of the filing PDF)20
118MPB Krazati 200 mg tab 18080739081218Listed by the FDA as Krazatiadagrasib200 mgtablet, coatedMirati Therapeutics, Inc78,447.08 (Schedule G, line 118, page 13 of the filing PDF)fewer than 6 (the count is not shown)
119olaparib (Lynparza) 150 mg Tab00310067912Listed by the FDA as Lynparzaolaparib150 mgtablet, film coatedAstraZeneca Pharmaceuticals LP78,210.90 (Schedule G, line 119, page 13 of the filing PDF)7
120MPB Kadcyla 160 mg SDV50242008701Listed by the FDA as Kadcylaado-trastuzumab emtansine20 mg/mLinjection, powder, lyophilized, for solutionGenentech, Inc.76,928.74 (Schedule G, line 120, page 13 of the filing PDF)17
121ribociclib (Kisqali) 200 mg/day (200 mg x 1) Tab00078086001Listed by the FDA as Kisqaliribociclib200 mgtablet, film coatedNovartis Pharmaceuticals Corporation76,772.60 (Schedule G, line 121, page 13 of the filing PDF)18
122Trulicity 1.5 mg/0.5 mL pen00002143480Listed by the FDA as Trulicitydulaglutide1.5 mg/0.5 mLinjection, solutionEli Lilly and Company76,729.91 (Schedule G, line 122, page 13 of the filing PDF)17
123MPB Lenvima 10 mg BPK cap 3062856071030Listed by the FDA as Lenvimalenvatinib10 mgcapsuleEisai Inc.76,718.04 (Schedule G, line 123, page 13 of the filing PDF)7
124Shingrix SDV 50 mcg 0.5 mL 1058160082311Listed by the FDA as Shingrixzoster vaccine recombinant, adjuvantedkitGlaxoSmithKline Biologicals SA75,681.19 (Schedule G, line 124, page 13 of the filing PDF)39
125MPB Jakafi 15 mg tab 6050881001560Listed by the FDA as Jakafiruxolitinib15 mgtabletIncyte Corporation74,926.48 (Schedule G, line 125, page 13 of the filing PDF)13
126MPB Alunbrig 180 mg tab 30CT63020018030Listed by the FDA as Alunbrigbrigatinib180 mgtablet, film coatedTakeda Pharmaceuticals America, Inc.73,273.87 (Schedule G, line 126, page 13 of the filing PDF)13
127MPB Alecensa 150 mg cap 24050242013001Listed by the FDA as Alecensaalectinib hydrochloride150 mgcapsuleGenentech, Inc.73,176.55 (Schedule G, line 127, page 13 of the filing PDF)6
128Entresto 24 mg-26 mg tablet00078065920Listed by the FDA as Entrestosacubitril and valsartan24 mg; 26 mgtablet, film coatedNovartis Pharmaceuticals Corporation72,489.30 (Schedule G, line 128, page 13 of the filing PDF)437
129(no name printed)secukinumab (Cosentyx UnoReady Pen) 300 mg/2 mL PnIj0007810706871,121.33 (Schedule G, line 129, page 13 of the filing PDF)29
130Invega Sustenna 234 mg kit50458056401Listed by the FDA as Invega Sustennapaliperidone palmitate234 mg/1.5 mLinjectionJanssen Pharmaceuticals, Inc.71,043.83 (Schedule G, line 130, page 13 of the filing PDF)60
131MPB Mektovi 15 mg tab 18070255001002Listed by the FDA as Mektovibinimetinib15 mgtablet, film coatedArray BioPharma Inc.70,095.64 (Schedule G, line 131, page 13 of the filing PDF)7
132Vivitrol 380 mg SUSR65757030001Listed by the FDA as VivitrolnaltrexonekitAlkermes, Inc.69,790.54 (Schedule G, line 132, page 13 of the filing PDF)101
133MPB Braftovi 75 mg cap 90x270255002501Listed by the FDA as Braftoviencorafenib75 mgcapsuleArray BioPharma Inc.69,467.86 (Schedule G, line 133, page 13 of the filing PDF)8
134MPB Mekinist 0.5 mg tab 3000078110515Listed by the FDA as Mekinisttrametinib0.5 mgtablet, film coatedNovartis Pharmaceuticals Corporation69,328.24 (Schedule G, line 134, page 14 of the filing PDF)38
135Dupixent 200 mg/1.14 mL Syring00024591801Listed by the FDA as Dupixentdupilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC69,140.60 (Schedule G, line 135, page 14 of the filing PDF)13
136MPB Lazcluze 240 mg tab 3057894024030Listed by the FDA as Lazcluzelazertinib240 mgtablet, film coatedJanssen Biotech, Inc.68,986.01 (Schedule G, line 136, page 14 of the filing PDF)fewer than 6 (the count is not shown)
137MPB Polivy 140 mg SDV50242010501Listed by the FDA as Polivypolatuzumab vedotin140 mg/7.52 mLinjection, powder, lyophilized, for solutionGenentech, Inc.68,654.59 (Schedule G, line 137, page 14 of the filing PDF)fewer than 6 (the count is not shown)
138MPB Lenvima 8 mg BPK cap 6062856070830Listed by the FDA as Lenvimalenvatinib4 mgcapsuleEisai Inc.66,005.92 (Schedule G, line 138, page 14 of the filing PDF)6
139MPB Reblozyl 25 mg SDV59572071101Listed by the FDA as Reblozylluspatercept25 mginjection, powder, lyophilized, for solutionCelgene Corporation65,831.69 (Schedule G, line 139, page 14 of the filing PDF)22
140MPB Lenvima 20 mg BPK cap 6062856072030Listed by the FDA as Lenvimalenvatinib10 mgcapsuleEisai Inc.64,449.09 (Schedule G, line 140, page 14 of the filing PDF)fewer than 6 (the count is not shown)
141MPB Soliris 10 mg/mL30 mL SDV DS25682000101Listed by the FDA as Soliriseculizumab300 mg/30 mLinjection, solution, concentrateAlexion Pharmaceuticals Inc.63,379.03 (Schedule G, line 141, page 14 of the filing PDF)13
142MPB Esbriet 801 mg tab 9050242012301Listed by the FDA as Esbrietpirfenidone801 mgtablet, coatedGenentech, Inc.62,538.08 (Schedule G, line 142, page 14 of the filing PDF)8
143MPB Ojjaara 200 mg tab 3081864010130Listed by the FDA as Ojjaaramomelotinib200 mgtabletGlaxoSmithKline LLC62,120.57 (Schedule G, line 143, page 14 of the filing PDF)fewer than 6 (the count is not shown)
144tremelimumab-actl 300 mg in sodium chloride 0.9% 100 mL chemo IVPB00310453530Listed by the FDA as Imjudotremelimumab300 mg/15 mLinjection, solutionAstraZeneca Pharmaceuticals LP60,842.00 (Schedule G, line 144, page 14 of the filing PDF)fewer than 6 (the count is not shown)
145capmatinib 150 mg Tab00078070956Listed by the FDA as Tabrectacapmatinib150 mgtablet, film coatedNovartis Pharmaceuticals Corporation60,774.23 (Schedule G, line 145, page 14 of the filing PDF)6
146MPB Stivarga 40 mg tab 21 CT450419017106Listed by the FDA as Stivargaregorafenib40 mgtablet, film coatedBayer HealthCare Pharmaceuticals Inc.59,914.88 (Schedule G, line 146, page 14 of the filing PDF)8
147Zepbound 7.5 mg/0.5 mL x 4PEND AM00002248480Listed by the FDA as Zepboundtirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company58,864.40 (Schedule G, line 147, page 14 of the filing PDF)74
148Inlyta tab 5 mg00069015111Listed by the FDA as Inlytaaxitinib5 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc58,027.99 (Schedule G, line 148, page 14 of the filing PDF)8
149Bendeka MDV 100 mg 4 mL63459034804Listed by the FDA as Bendekabendamustine hydrochloride25 mg/mLinjection, solutionTeva Pharmaceuticals USA, Inc.57,919.66 (Schedule G, line 149, page 14 of the filing PDF)75
150Bosulif 100 mg tablet00069013501Listed by the FDA as Bosulifbosutinib100 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc57,324.41 (Schedule G, line 150, page 14 of the filing PDF)14
151octreotide LAR 20 mg PWDI00078081881Listed by the FDA as Sandostatin LAR Depotoctreotide acetatekitNovartis Pharmaceuticals Corporation56,665.27 (Schedule G, line 151, page 14 of the filing PDF)78
152MPB Inrebic 100 mg cap 12059572072012Listed by the FDA as Inrebicfedratinib hydrochloride100 mgcapsuleCelgene Corporation55,910.84 (Schedule G, line 152, page 14 of the filing PDF)fewer than 6 (the count is not shown)
153siponimod (Mayzent) 2 mg Tab00078098615Listed by the FDA as Mayzentsiponimod2 mgtablet, film coatedNovartis Pharmaceuticals Corporation55,654.31 (Schedule G, line 153, page 14 of the filing PDF)9
154nivolumab 40 mg/4 mL INJ00003377211Listed by the FDA as Opdivonivolumab10 mg/mLinjectionE.R. Squibb & Sons, L.L.C.54,644.18 (Schedule G, line 154, page 14 of the filing PDF)24
155Basaglar KwikPen 3 mL 500002771559Listed by the FDA as Basaglar KwikPeninsulin glargine100 IU/mLinjection, solutionEli Lilly and Company54,287.20 (Schedule G, line 155, page 14 of the filing PDF)240
156MPB Orgovyx 120 mg tab 3072974012001Listed by the FDA as Orgovyxrelugolix120 mgtablet, film coatedSumitomo Pharma America, Inc.52,991.22 (Schedule G, line 156, page 14 of the filing PDF)28
157Wegovy 2.4 mg/0.75 mL pen00169452414Listed by the FDA as Wegovysemaglutide2.4 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP51,602.85 (Schedule G, line 157, page 14 of the filing PDF)86
158HyperRAB 1,500 units/5 mL SOLN13533031805Listed by the FDA as HyperRABrabies immune globulin (human)300 IU/mLinjection, solutionGrifols USA, LLC51,455.68 (Schedule G, line 158, page 14 of the filing PDF)30
159MPB Monjuvi 200 mg SDV50881001303Listed by the FDA as Monjuvitafasitamab-cxix200 mg/5 mLinjection, powder, lyophilized, for solutionIncyte Corporation51,328.50 (Schedule G, line 159, page 14 of the filing PDF)50
160Breztri Aerosphere inhaler00310461612Listed by the FDA as Breztribudesonide, glycopyrrolate, and formoterol fumarate160 mcg; 9 mcg; 4.8 mcgaerosol, meteredAstraZeneca Pharmaceuticals LP51,036.19 (Schedule G, line 160, page 14 of the filing PDF)235
161MPB Ocrevus 300 mg/10 mL SDV50242015001Listed by the FDA as Ocrevusocrelizumab300 mg/10 mLinjectionGenentech, Inc.50,978.22 (Schedule G, line 161, page 14 of the filing PDF)fewer than 6 (the count is not shown)
162MPB Octagam 10% 20 g/200 mL68982085004Listed by the FDA as Octagam Immune Globulin (Human)immune globulin100 mg/mLsolutionOctapharma USA Inc49,454.95 (Schedule G, line 162, page 14 of the filing PDF)38
163MPB Phesgo 1,200 mg/10 mL SDV kit50242026001Listed by the FDA as Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf600 mg/10 mL; 600 mg/10 mL; 20,000 units/10 mLinjection, solutionGenentech, Inc.49,387.50 (Schedule G, line 163, page 14 of the filing PDF)10
164Tyenne auto inj 162 mg/0.9 mL 165219058401Listed by the FDA as Tyennetocilizumab-aazg162 mg/0.9 mLinjection, solutionFresenius Kabi USA, LLC49,093.88 (Schedule G, line 164, page 14 of the filing PDF)120
165Zepbound 10 mg/0.5 mL pen00002247180Listed by the FDA as Zepboundtirzepatide10 mg/0.5 mLinjection, solutionEli Lilly and Company48,801.95 (Schedule G, line 165, page 14 of the filing PDF)7
166MPB Kadcyla 100 mg SDV50242008801Listed by the FDA as Kadcylaado-trastuzumab emtansine20 mg/mLinjection, powder, lyophilized, for solutionGenentech, Inc.48,089.31 (Schedule G, line 166, page 14 of the filing PDF)17
167Durolane 60 mg/3 mL PRSY8913020200148,005.86 (Schedule G, line 167, page 14 of the filing PDF)41
168MPB Idhifa 100 mg tab 3059572071030Listed by the FDA as Idhifaenasidenib mesylate100 mgtablet, film coatedCelgene Corporation46,515.58 (Schedule G, line 168, page 14 of the filing PDF)fewer than 6 (the count is not shown)
169semaglutide, weight loss, (Wegovy) 0.25 mg/0.5 mL pen-injector00169452514Listed by the FDA as Wegovysemaglutide0.25 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP45,223.35 (Schedule G, line 169, page 14 of the filing PDF)81
170MPB Enjaymo 1,100 mg/22 mL SDV55292082001Listed by the FDA as Enjaymosutimlimab-jome50 mg/mLinjection, solution, concentrateRecordati Rare Diseases, Inc.45,205.20 (Schedule G, line 170, page 14 of the filing PDF)30
171MPB Inqovi 35 mg/100 mg tab 564842072709Listed by the FDA as Inqovicedazuridine and decitabine100 mg; 35 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd.45,120.56 (Schedule G, line 171, page 14 of the filing PDF)7
172Xifaxan tab 550 mg 6065649030302Listed by the FDA as Xifaxanrifaximin550 mgtabletSalix Pharmaceuticals, Inc.45,001.08 (Schedule G, line 172, page 15 of the filing PDF)65
173Botox 100 units vial00023114501Listed by the FDA as BotoxonabotulinumtoxinA100 USP unitsinjection, powder, lyophilized, for solutionAllergan, Inc.44,857.60 (Schedule G, line 173, page 15 of the filing PDF)86
174Bosulif 500 mg tablet00069013601Listed by the FDA as Bosulifbosutinib500 mgtablet, film coatedPfizer Laboratories Div Pfizer Inc44,825.91 (Schedule G, line 174, page 15 of the filing PDF)12
175Dovato TB 50/300 mg 3049702024613Listed by the FDA as Dovatodolutegravir sodium and lamivudine50 mg; 300 mgtablet, film coatedViiV Healthcare Company44,139.63 (Schedule G, line 175, page 15 of the filing PDF)23
176semaglutide, weight loss, (Wegovy) 1.7 mg/0.75 mL pen-injector00169451714Listed by the FDA as Wegovysemaglutide1.7 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP43,158.06 (Schedule G, line 176, page 15 of the filing PDF)71
177MPB Fotivda 0.89 mg caps 2145629008902Listed by the FDA as Fotivdativozanib0.89 mgcapsuleAVEO Pharmaceuticals, Inc.42,752.70 (Schedule G, line 177, page 15 of the filing PDF)fewer than 6 (the count is not shown)
178MPB Fotivda 0.89 mg caps 2145629008901Listed by the FDA as Fotivdativozanib0.89 mgcapsuleAVEO Pharmaceuticals, Inc.the product is listed, not this package42,219.70 (Schedule G, line 178, page 15 of the filing PDF)fewer than 6 (the count is not shown)
179Orencia Clickject 125 mg/mL00003218851Listed by the FDA as Orenciaabatacept125 mg/mLinjection, solutionE.R. Squibb & Sons, L.L.C.42,076.33 (Schedule G, line 179, page 15 of the filing PDF)36
180TNKase 50 mg KIT50242012047Listed by the FDA as TNKasetenecteplasekitGenentech, Inc.41,341.36 (Schedule G, line 180, page 15 of the filing PDF)40
181Trulicity 0.75 mg/0.5 mL pen 400002143380Listed by the FDA as Trulicitydulaglutide0.75 mg/0.5 mLinjection, solutionEli Lilly and Company40,755.43 (Schedule G, line 181, page 15 of the filing PDF)112
182Cosentyx Sensoready 150 mg pen00078063968Listed by the FDA as Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation40,470.19 (Schedule G, line 182, page 15 of the filing PDF)fewer than 6 (the count is not shown)
183Zepbound 12.5 mg/0.5 mL pen00002246080Listed by the FDA as Zepboundtirzepatide12.5 mg/0.5 mLinjection, solutionEli Lilly and Company39,719.49 (Schedule G, line 183, page 15 of the filing PDF)fewer than 6 (the count is not shown)
184Abilify Maintena ER 400 mg kit59148024512Listed by the FDA as Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc.39,709.41 (Schedule G, line 184, page 15 of the filing PDF)27
185Kcentra 500 units KIT63833038602Listed by the FDA as Kcentraprothrombin, coagulation factor VII human, coagulation factor IX human, coagulation factor X human, protein C, protein S human, and waterkitCSL Behring GmbH39,536.42 (Schedule G, line 185, page 15 of the filing PDF)52
186MPB Empliciti 300 mg vial00003229111Listed by the FDA as Emplicitielotuzumab300 mginjection, powder, lyophilized, for solutionE.R. Squibb & Sons, L.L.C.38,960.48 (Schedule G, line 186, page 15 of the filing PDF)23
187Zepbound 15 mg/0.5 mL pen00002245780Listed by the FDA as Zepboundtirzepatide15 mg/0.5 mLinjection, solutionEli Lilly and Company38,932.39 (Schedule G, line 187, page 15 of the filing PDF)6
188Stelara PFS 45 mg/0.5 mL 157894006003Listed by the FDA as Stelaraustekinumab45 mg/0.5 mLinjection, solutionJanssen Biotech, Inc.38,715.02 (Schedule G, line 188, page 15 of the filing PDF)10
189olaparib (Lynparza) 100 mg Tab00310066812Listed by the FDA as Lynparzaolaparib100 mgtablet, film coatedAstraZeneca Pharmaceuticals LP38,397.12 (Schedule G, line 189, page 15 of the filing PDF)fewer than 6 (the count is not shown)
190semaglutide, weight loss, (Wegovy) 1 mg/0.5 mL pen-injector00169450114Listed by the FDA as Wegovysemaglutide1 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP37,902.64 (Schedule G, line 190, page 15 of the filing PDF)71
191Prolia 60 mg/mL SOSY55513071021Listed by the FDA as Proliadenosumab60 mg/mLinjectionAmgen, Inc37,444.18 (Schedule G, line 191, page 15 of the filing PDF)67
192Verzenio 200 mg tablet00002621654Listed by the FDA as Verzenioabemaciclib200 mgtabletEli Lilly and Company37,386.50 (Schedule G, line 192, page 15 of the filing PDF)fewer than 6 (the count is not shown)
193MPB Ilumya 100 mg/1 mL PFS47335017795Listed by the FDA as Ilumyatildrakizumab-asmn100 mg/mLinjection, solutionSun Pharmaceutical Industries, Inc.37,334.02 (Schedule G, line 193, page 15 of the filing PDF)fewer than 6 (the count is not shown)
194Brilinta 90 mg tablet00186077760Listed by the FDA as Brilintaticagrelor90 mgtabletAstraZeneca Pharmaceuticals LP37,212.56 (Schedule G, line 194, page 15 of the filing PDF)72
195Eliquis 2.5 mg tablet00003089321Listed by the FDA as Eliquisapixaban2.5 mgtablet, film coatedE.R. Squibb & Sons, L.L.C.37,052.13 (Schedule G, line 195, page 15 of the filing PDF)472
196Simlandi 40 mg/0.4 mL AI 251759040202Listed by the FDA as Simlandiadalimumab-ryvkkitTeva Pharmaceuticals USA, Inc.37,044.00 (Schedule G, line 196, page 15 of the filing PDF)72
197Dapagliflozin Propanediol 10 mg TABS66993045730Listed by the FDA as Dapagliflozin10 mgtablet, film coatedPrasco Laboratories36,621.73 (Schedule G, line 197, page 15 of the filing PDF)230
198Nurtec ODT 75 mg 872618300002Listed by the FDA as Nurtec ODTrimegepant sulfate75 mgtablet, orally disintegratingPfizer Laboratories Div Pfizer Inc36,607.72 (Schedule G, line 198, page 15 of the filing PDF)137
199Adalimumab-adaz pen 40 mg/0.4 mL61314032720Listed by the FDA as Adalimumabadalimumab-adaz40 mg/0.4 mLinjection, solutionSandoz Inc35,990.04 (Schedule G, line 199, page 15 of the filing PDF)66
200MPB Braftovi 75 mg cap 60x270255002503Listed by the FDA as Braftoviencorafenib75 mgcapsuleArray BioPharma Inc.35,935.40 (Schedule G, line 200, page 15 of the filing PDF)6
201capivasertib (Truqap) 200 mg tablet00310950101Listed by the FDA as Truqapcapivasertib200 mgtablet, film coatedAstraZeneca Pharmaceuticals LP35,310.22 (Schedule G, line 201, page 15 of the filing PDF)fewer than 6 (the count is not shown)
202MPB Cabometyx 20 mg tab 3042388002446Listed by the FDA as Cabometyxcabozantinib20 mgtabletExelixis, Inc.35,064.66 (Schedule G, line 202, page 15 of the filing PDF)fewer than 6 (the count is not shown)
203MPB Gamunex-C 10 g/100 mL13533080071Listed by the FDA as Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC34,055.84 (Schedule G, line 203, page 15 of the filing PDF)52
204Acetaminophen 10 mg/mL SOLN63323043400Listed by the FDA as Acetaminophen10 mg/mLinjectionFresenius Kabi USA, LLC33,972.62 (Schedule G, line 204, page 15 of the filing PDF)10,589
205MPB Benlysta SC PFS 200 mg/mL 449401008847Listed by the FDA as Benlystabelimumab200 mg/mLsolutionGlaxoSmithKline LLC33,343.91 (Schedule G, line 205, page 15 of the filing PDF)10
206Ruxience 100 mg/10 mL SOLN00069023801Listed by the FDA as Ruxiencerituximab-pvvr100 mg/10 mLinjection, solutionPfizer Laboratories Div Pfizer Inc33,118.08 (Schedule G, line 206, page 15 of the filing PDF)170
207Kevzara PFS 200 mg/1.14 mL 200024591001Listed by the FDA as Kevzarasarilumab200 mg/1.14 mLinjection, solutionSanofi-Aventis U.S. LLC32,166.93 (Schedule G, line 207, page 15 of the filing PDF)17
208semaglutide (Rybelsus) 14 mg Tab00169431430Listed by the FDA as Rybelsusoral semaglutide14 mgtabletNovo Nordisk Pharmaceutical Industries, LP31,521.91 (Schedule G, line 208, page 15 of the filing PDF)56
209Retacrit 40,000 units/mL SOLN00069130904Listed by the FDA as Retacritepoetin alfa-epbx40,000 IU/mLinjection, solutionPfizer Laboratories Div Pfizer Inc30,873.76 (Schedule G, line 209, page 15 of the filing PDF)160
210durvalumab (Imfinzi) 860 mg in sodium chloride 0.9% 250 mL IVPB031045001230,287.32 (Schedule G, line 210, page 16 of the filing PDF)20
211eltrombopag olamine (Promacta) 50 mg tablet00078068615Listed by the FDA as Promactaeltrombopag olamine50 mgtablet, film coatedNovartis Pharmaceuticals Corporation30,287.32 (Schedule G, line 211, page 16 of the filing PDF)19
212HyperRAB 300 units/mL SOLN13533031801Listed by the FDA as HyperRABrabies immune globulin (human)300 IU/mLinjection, solutionGrifols USA, LLC29,908.80 (Schedule G, line 212, page 16 of the filing PDF)39
213MPB Kyprolis 30 mg inj pwd76075010201Listed by the FDA as Kyproliscarfilzomib30 mg/15 mLinjection, powder, lyophilized, for solutionOnyx Pharmaceuticals, Inc.29,558.77 (Schedule G, line 213, page 16 of the filing PDF)34
214Enbrel Mini PF cart 50 mg/mL 458406004404Listed by the FDA as Enbreletanercept50 mg/mLsolutionImmunex Corporation29,331.31 (Schedule G, line 214, page 16 of the filing PDF)301
215MPB Jakafi 25 mg tab 6050881002560Listed by the FDA as Jakafiruxolitinib25 mgtabletIncyte Corporation29,049.16 (Schedule G, line 215, page 16 of the filing PDF)fewer than 6 (the count is not shown)
216risankizumab-rzaa (Skyrizi) 150 mg/mL Syrg00074105001Listed by the FDA as Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc.28,799.24 (Schedule G, line 216, page 16 of the filing PDF)fewer than 6 (the count is not shown)
217semaglutide, weight loss, (Wegovy) 0.5 mg/0.5 mL pen-injector00169450514Listed by the FDA as Wegovysemaglutide0.5 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP28,727.42 (Schedule G, line 217, page 16 of the filing PDF)51
218MPB Bavencio 200 mg/10 mL SDV44087353501Listed by the FDA as Bavencioavelumab20 mg/mLinjection, solution, concentrateEMD Serono, Inc.27,909.00 (Schedule G, line 218, page 16 of the filing PDF)20
219MPB Xolair 300 mg/2 mL auto inj50242022755Listed by the FDA as Xolairomalizumab300 mg/2 mLinjection, solutionGenentech, Inc.27,716.39 (Schedule G, line 219, page 16 of the filing PDF)15
220octreotide LAR 30 mg PWDI00078082581Listed by the FDA as Sandostatin LAR Depotoctreotide acetatekitNovartis Pharmaceuticals Corporation27,694.33 (Schedule G, line 220, page 16 of the filing PDF)19
221inclisiran (Leqvio) 284 mg/1.5 mL Syrg00078100060Listed by the FDA as Leqvioinclisiran284 mg/1.5 mLinjection, solutionNovartis Pharmaceuticals Corporation27,611.19 (Schedule G, line 221, page 16 of the filing PDF)12
222Vumerity 231 mg cap64406002003Listed by the FDA as Vumeritydiroximel fumarate231 mgcapsuleBiogen Inc.27,114.78 (Schedule G, line 222, page 16 of the filing PDF)10
223MPB Apretude 600 mg/3 mL kit49702026423Listed by the FDA as ApretudecabotegravirkitViiV Healthcare Company27,025.74 (Schedule G, line 223, page 16 of the filing PDF)9
224Incruse Ellipta 62.5 mcg inh00173087310Listed by the FDA as Incruse Elliptaumeclidinium62.5 mcgaerosol, powderGlaxoSmithKline LLC27,020.82 (Schedule G, line 224, page 16 of the filing PDF)228
225Rybelsus 7 mg tablet00169430730Listed by the FDA as Rybelsusoral semaglutide7 mgtabletNovo Nordisk Pharmaceutical Industries, LP26,870.76 (Schedule G, line 225, page 16 of the filing PDF)46
226niraparib (Zejula) 200 mg Tab00173091213Listed by the FDA as Zejulaniraparib200 mgtablet, film coatedGlaxoSmithKline LLC26,837.74 (Schedule G, line 226, page 16 of the filing PDF)fewer than 6 (the count is not shown)
227Pomalyst 2 mg capsule59572050221Listed by the FDA as Pomalystpomalidomide2 mgcapsuleCelgene Corporation26,722.29 (Schedule G, line 227, page 16 of the filing PDF)fewer than 6 (the count is not shown)
228Revlimid 10 mg capsule59572041028Listed by the FDA as Revlimidlenalidomide10 mgcapsuleCelgene Corporation25,789.86 (Schedule G, line 228, page 16 of the filing PDF)21
229MPB Cyramza 500 mg/50 mL SDV00002767801Listed by the FDA as Cyramzaramucirumab10 mg/mLsolutionEli Lilly and Company25,640.12 (Schedule G, line 229, page 16 of the filing PDF)fewer than 6 (the count is not shown)
230Paxlovid new 300/100 mg T standard00069532130Listed by the FDA as Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc25,508.11 (Schedule G, line 230, page 16 of the filing PDF)24
231RabAvert SUSR50632001001Listed by the FDA as RabAvertrabies vaccinekitBavarian Nordic A/S25,457.77 (Schedule G, line 231, page 16 of the filing PDF)63
232Deferiprone TB 500Mgtaro100@=@51672419601Listed by the FDA as Deferiprone500 mgtabletSun Pharmaceutical Industries, Inc.25,114.83 (Schedule G, line 232, page 16 of the filing PDF)11
233MPB Nerlynx 40 mg tab 18070437024018Listed by the FDA as Nerlynxneratinib40 mgtabletPuma Biotechnology, Inc.24,551.76 (Schedule G, line 233, page 16 of the filing PDF)fewer than 6 (the count is not shown)
234MPB Darzalex 400 mg/20 mL SDV57894050520Listed by the FDA as Darzalex IVdaratumumab100 mg/5 mLinjection, solution, concentrateJanssen Biotech, Inc.24,527.81 (Schedule G, line 234, page 16 of the filing PDF)14
235Olumiant tab 2 mg 3000002418230Listed by the FDA as Olumiantbaricitinib2 mgtablet, film coatedEli Lilly and Company24,451.97 (Schedule G, line 235, page 16 of the filing PDF)14
236Santyl 250 units/g OINT50484001030Listed by the FDA as Collagenase Santyl250 units/gointmentSmith & Nephew, Inc24,266.10 (Schedule G, line 236, page 16 of the filing PDF)41
237Dasatinib TB 100 mg APX 30@60505363103Listed by the FDA as Dasatinib100 mgtablet, film coatedApotex Corp.24,255.35 (Schedule G, line 237, page 16 of the filing PDF)15
238MPB Nerlynx 40 mg TB 13370437024033Listed by the FDA as Nerlynxneratinib40 mgtabletPuma Biotechnology, Inc.24,044.36 (Schedule G, line 238, page 16 of the filing PDF)fewer than 6 (the count is not shown)
239Adbry Autoinj 300 mg/2 mL 2PK50222035002Listed by the FDA as Adbrytralokinumab-ldrm300 mg/2 mLinjection, solutionLEO Pharma Inc.23,841.51 (Schedule G, line 239, page 16 of the filing PDF)11
240Opzelura crm 1.5% 60 g50881000705Listed by the FDA as Opzeluraruxolitinib15 mg/gcreamIncyte Corporation23,568.01 (Schedule G, line 240, page 16 of the filing PDF)21
241ritlecitinib (Litfulo) 50 mg cap00069033428Listed by the FDA as Litfuloritlecitinib50 mgcapsulePfizer Laboratories Div Pfizer Inc23,548.58 (Schedule G, line 241, page 16 of the filing PDF)10
242MPB Cabometyx 40 mg tab 3042388002546Listed by the FDA as Cabometyxcabozantinib40 mgtabletExelixis, Inc.23,252.10 (Schedule G, line 242, page 16 of the filing PDF)fewer than 6 (the count is not shown)
243Gilenya 0.5 mg capsule00078060715Listed by the FDA as Gilenyafingolimod hcl0.5 mgcapsuleNovartis Pharmaceuticals Corporation22,988.96 (Schedule G, line 243, page 16 of the filing PDF)fewer than 6 (the count is not shown)
244Hizentra 10 gram/50 mL syringe44206045525Listed by the FDA as Hizentrahuman immunoglobulin G0.2 g/mLliquidCSL Behring AG22,684.98 (Schedule G, line 244, page 16 of the filing PDF)40
245MPB Nplate 250 mcg/0.5 mL SDV55513022101Listed by the FDA as Nplateromiplostim250 mcg/0.5 mLinjection, powder, lyophilized, for solutionAmgen, Inc22,406.76 (Schedule G, line 245, page 16 of the filing PDF)24
246Neulasta Onpro 6 mg/0.6 mL SOSY55513019201Listed by the FDA as NeulastapegfilgrastimkitAmgen, Inc22,181.58 (Schedule G, line 246, page 16 of the filing PDF)89
247Invega Sustenna 156 mg kit50458056301Listed by the FDA as Invega Sustennapaliperidone palmitate156 mg/mLinjectionJanssen Pharmaceuticals, Inc.22,010.18 (Schedule G, line 247, page 16 of the filing PDF)28
248Erbitux VL 2 mg/mL 50 mL66733094823Listed by the FDA as Erbituxcetuximab2 mg/mLsolutionImClone LLC21,918.33 (Schedule G, line 248, page 17 of the filing PDF)42
249Mvasi SDV 400 mg/16 mL 155513020701Listed by the FDA as Mvasibevacizumab-awwb400 mg/16 mLinjection, solutionAmgen, Inc21,811.09 (Schedule G, line 249, page 17 of the filing PDF)31
250Exparel 1.3% SUSP65250013309Listed by the FDA as Exparelbupivacaine13.3 mg/mLinjection, suspension, liposomalPacira Pharmaceuticals, Inc.21,434.43 (Schedule G, line 250, page 17 of the filing PDF)156
251Abilify Maintena PF syr 400 mg59148007280Listed by the FDA as Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc.21,403.39 (Schedule G, line 251, page 17 of the filing PDF)16
252MPB Adcetris 50 mg VL LY DS51144005001Listed by the FDA as Adcetrisbrentuximab vedotin50 mg/10.5 mLinjection, powder, lyophilized, for solutionSeagen Inc.21,236.90 (Schedule G, line 252, page 17 of the filing PDF)6
253MPB Nplate 125 mcg/0.25 mL SDV55513022301Listed by the FDA as Nplateromiplostim125 mcg/0.25 mLinjection, powder, lyophilized, for solutionAmgen, Inc21,157.01 (Schedule G, line 253, page 17 of the filing PDF)25
254momelotinib 150 mg Tab81864010230Listed by the FDA as Ojjaaramomelotinib150 mgtabletGlaxoSmithKline LLC20,974.86 (Schedule G, line 254, page 17 of the filing PDF)fewer than 6 (the count is not shown)
255MPB Gamunex-C 40 g/400 mL13533080040Listed by the FDA as Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC20,957.62 (Schedule G, line 255, page 17 of the filing PDF)8
256Qulipta tab 60 mg00074709430Listed by the FDA as Quliptaatogepant60 mgtabletAbbVie Inc.20,742.41 (Schedule G, line 256, page 17 of the filing PDF)62
257Combivent Respimat 20-100 mcg00597002402Listed by the FDA as Combivent Respimatipratropium bromide and albuterol20 mcg; 100 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc.20,675.81 (Schedule G, line 257, page 17 of the filing PDF)32
258Tivicay 50 mg TABS49702022813Listed by the FDA as Tivicaydolutegravir sodium50 mgtablet, film coatedViiV Healthcare Company20,187.12 (Schedule G, line 258, page 17 of the filing PDF)44
259TNKase 50 mg KIT50242017601Listed by the FDA as TNKasetenecteplasekitGenentech, Inc.19,982.29 (Schedule G, line 259, page 17 of the filing PDF)17
260Symbicort 160-4.5 mcg/ACT AERO00186037028Listed by the FDA as Symbicortbudesonide and formoterol fumarate dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP19,783.47 (Schedule G, line 260, page 17 of the filing PDF)623
261Stiolto Respimat inhaler (60)00597015561Listed by the FDA as Stiolto Respimattiotropium bromide and olodaterol3.124 mcg; 2.736 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc.19,497.56 (Schedule G, line 261, page 17 of the filing PDF)134
262Breo Ellipta 100-25 mcg Inhalr00173085910Listed by the FDA as Breo Elliptafluticasone furoate and vilanterol trifenatate100 mcg; 25 mcgpowderGlaxoSmithKline LLC19,314.22 (Schedule G, line 262, page 17 of the filing PDF)214
263Veklury 100 mg SOLR61958290102Listed by the FDA as Vekluryremdesivir100 mginjection, powder, lyophilized, for solutionGilead Sciences, Inc.19,308.00 (Schedule G, line 263, page 17 of the filing PDF)fewer than 6 (the count is not shown)
264MPB Ibrance 100 mg cap 2100069018821Listed by the FDA as Ibrancepalbociclib100 mgcapsulePfizer Laboratories Div Pfizer Inc18,837.72 (Schedule G, line 264, page 17 of the filing PDF)fewer than 6 (the count is not shown)
265Entresto 49 mg-51 mg tablet00078077720Listed by the FDA as Entrestosacubitril and valsartan49 mg; 51 mgtablet, film coatedNovartis Pharmaceuticals Corporation18,827.95 (Schedule G, line 265, page 17 of the filing PDF)141
266MPB Kyprolis 10 mg inj pwd76075010301Listed by the FDA as Kyproliscarfilzomib10 mg/5 mLinjection, powder, lyophilized, for solutionOnyx Pharmaceuticals, Inc.18,102.34 (Schedule G, line 266, page 17 of the filing PDF)55
267Steqeyma PFS 90 mg/mL 172606002801Listed by the FDA as Steqeymaustekinumab-stba90 mg/mLinjection, solutionCELLTRION USA, Inc.18,066.24 (Schedule G, line 267, page 17 of the filing PDF)16
268Epinephrine 0.3 mg auto-Inject00093598627Listed by the FDA as Epinephrine0.3 mg/0.3 mLinjectionTeva Pharmaceuticals USA, Inc.17,995.59 (Schedule G, line 268, page 17 of the filing PDF)193
269capivasertib (Truqap) 160 mg Tab00310950002Listed by the FDA as Truqapcapivasertib160 mgtablet, film coatedAstraZeneca Pharmaceuticals LP17,903.54 (Schedule G, line 269, page 17 of the filing PDF)fewer than 6 (the count is not shown)
270MPB Jakafi 5 mg tab 6050881000560Listed by the FDA as Jakafiruxolitinib5 mgtabletIncyte Corporation17,583.60 (Schedule G, line 270, page 17 of the filing PDF)fewer than 6 (the count is not shown)
271Ubrelvy 100 mg tablets00023650110Listed by the FDA as Ubrelvyubrogepant100 mgtabletAllergan, Inc.17,383.27 (Schedule G, line 271, page 17 of the filing PDF)fewer than 6 (the count is not shown)
272Entresto 97-103 mg TABS00078069620Listed by the FDA as Entrestosacubitril and valsartan97 mg; 103 mgtablet, film coatedNovartis Pharmaceuticals Corporation17,208.00 (Schedule G, line 272, page 17 of the filing PDF)73
273Emgality inj pen 120 mg/mL 100002143611Listed by the FDA as Emgalitygalcanezumab-gnlm120 mg/mLinjection, solutionEli Lilly and Company16,740.44 (Schedule G, line 273, page 17 of the filing PDF)34
274Abraxane SDV 100 mg68817013450Listed by the FDA as Abraxanepaclitaxel100 mg/20 mLinjection, powder, lyophilized, for suspensionAbraxis BioScience, LLC16,692.96 (Schedule G, line 274, page 17 of the filing PDF)20
275Vraylar cap 1.5 mg 3061874011530Listed by the FDA as Vraylarcariprazine1.5 mgcapsule, gelatin coatedAllergan, Inc.16,176.21 (Schedule G, line 275, page 17 of the filing PDF)21
276Breo Ellipta 200-25 mcg Inhalr00173088210Listed by the FDA as Breo Elliptafluticasone furoate and vilanterol trifenatate200 mcg; 25 mcgpowderGlaxoSmithKline LLC16,169.19 (Schedule G, line 276, page 17 of the filing PDF)180
277Abilify Maintena 400 mg kit5914800197115,548.74 (Schedule G, line 277, page 17 of the filing PDF)13
278Zerbaxa 1.5 (1-0.5) GM SOLR67919003001Listed by the FDA as Zerbaxaceftolozane and tazobactam1 g/10 mL; 0.5 g/10 mLinjection, powder, lyophilized, for solutionMerck Sharp & Dohme LLC15,272.11 (Schedule G, line 278, page 17 of the filing PDF)12
279Rexulti 1 mg TABS59148003713Listed by the FDA as Rexultibrexpiprazole1 mgtabletOtsuka America Pharmaceutical, Inc.15,260.53 (Schedule G, line 279, page 17 of the filing PDF)26
280Budesonide/FORM 160/4.5 mcg(120 inh)00310737020Listed by the FDA as Budesonide and Formoterol Fumarate Dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP15,060.51 (Schedule G, line 280, page 17 of the filing PDF)163
281Toujeo Max Solostr 300 units/mL00024587102Listed by the FDA as Toujeo Maxinsulin glargine300 units/mLinjection, solutionSanofi-Aventis U.S. LLC14,986.82 (Schedule G, line 281, page 17 of the filing PDF)14
282Gamunex-C 20 gram/200 mL vial13533080024Listed by the FDA as Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC14,740.04 (Schedule G, line 282, page 17 of the filing PDF)27
283Diprivan 200 mg/20 mL EMUL63323026929Listed by the FDA as Diprivanpropofol10 mg/mLinjection, emulsionFresenius Kabi USA, LLC14,634.45 (Schedule G, line 283, page 17 of the filing PDF)13,759
284MPB PHS Neulasta 6 mg/0.6 mL PFS55513019001Listed by the FDA as Neulastapegfilgrastim6 mg/0.6 mLinjectionAmgen, Inc14,595.41 (Schedule G, line 284, page 17 of the filing PDF)34
285Sivextro tab 200 mg 3067919004104Listed by the FDA as Sivextrotedizolid phosphate200 mgtablet, film coatedMerck Sharp & Dohme LLC14,261.32 (Schedule G, line 285, page 17 of the filing PDF)fewer than 6 (the count is not shown)
286Belrapzo inj 100 mg/4 mL42367052125Listed by the FDA as Belrapzobendamustine hydrochloride100 mg/4 mLinjectionEagle Pharmaceuticals, Inc14,216.67 (Schedule G, line 286, page 18 of the filing PDF)31
287Rexulti 0.5 mg TABS59148003613Listed by the FDA as Rexultibrexpiprazole0.5 mgtabletOtsuka America Pharmaceutical, Inc.14,104.88 (Schedule G, line 287, page 18 of the filing PDF)18
288Tymlos 80 mcg dose pen Injectr70539000102Listed by the FDA as Tymlosabaloparatide3.12 mg/1.56 mLinjection, solutionRadius Health, Inc.14,064.42 (Schedule G, line 288, page 18 of the filing PDF)75
289Dapagliflozin Propanediol 5 mg TABS66993045630Listed by the FDA as Dapagliflozin5 mgtablet, film coatedPrasco Laboratories14,044.19 (Schedule G, line 289, page 18 of the filing PDF)82
290Emgality inj PFS 120 mg 100002237711Listed by the FDA as Emgalitygalcanezumab-gnlm120 mg/mLinjection, solutionEli Lilly and Company13,758.92 (Schedule G, line 290, page 18 of the filing PDF)28
291MPB Leukine 250 mcg pwd SDV 571837584305Listed by the FDA as Leukinesargramostim250 mcg/mLinjection, powder, lyophilized, for solutionPartner Therapeutics, Inc.13,434.60 (Schedule G, line 291, page 18 of the filing PDF)24
292Invega Trinza PFS 546 mg 150458060801Listed by the FDA as Invega Trinzapaliperidone palmitate546 mg/1.75 mLinjection, suspension, extended releaseJanssen Pharmaceuticals, Inc13,414.18 (Schedule G, line 292, page 18 of the filing PDF)fewer than 6 (the count is not shown)
293Descovy 200 mg/25 mg tablets61958200201Listed by the FDA as Descovyemtricitabine and tenofovir alafenamide200 mg; 25 mgtabletGilead Sciences, Inc.13,203.41 (Schedule G, line 293, page 18 of the filing PDF)31
294Biktarvy 30-120-15 mg tablet61958250501Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate30 mg; 120 mg; 15 mgtabletGilead Sciences, Inc.13,203.41 (Schedule G, line 294, page 18 of the filing PDF)fewer than 6 (the count is not shown)
295Vraylar cap 3 mg 3061874013030Listed by the FDA as Vraylarcariprazine3 mgcapsule, gelatin coatedAllergan, Inc.13,003.26 (Schedule G, line 295, page 18 of the filing PDF)17
296Venofer 20 mg/mL SOLN00517234010Listed by the FDA as Venoferiron sucrose20 mg/mLinjection, solutionAmerican Regent, Inc.12,929.08 (Schedule G, line 296, page 18 of the filing PDF)247
297Glatopa 40 mg/mL syringe00781325089Listed by the FDA as Glatopaglatiramer acetate40 mg/mLinjection, solutionSandoz Inc12,904.71 (Schedule G, line 297, page 18 of the filing PDF)27
298Tresiba Flextouch 100 units/mL00169266015Listed by the FDA as Tresibainsulin degludec100 units/mLinjection, solutionNovo Nordisk12,777.63 (Schedule G, line 298, page 18 of the filing PDF)99
299Privigen 5 g/50 mL SOLN44206043605Listed by the FDA as Privigenhuman immunoglobulin G5 g/50 mLliquidCSL Behring AG12,458.15 (Schedule G, line 299, page 18 of the filing PDF)43
300Tyenne auto inj 162 mg/0.9 mL 165219059601Listed by the FDA as Tyennetocilizumab-aazg162 mg/0.9 mLinjection, solutionFresenius Kabi USA, LLC12,390.60 (Schedule G, line 300, page 18 of the filing PDF)30
301Austedo XR 30 mg tablet68546047356Listed by the FDA as Austedo XRdeutetrabenazine30 mgtablet, film coated, extended releaseTeva Neuroscience, Inc.12,353.86 (Schedule G, line 301, page 18 of the filing PDF)fewer than 6 (the count is not shown)
302eltrombopag olamine (Promacta) 75 mg Tab00078068715Listed by the FDA as Promactaeltrombopag olamine75 mgtablet, film coatedNovartis Pharmaceuticals Corporation12,225.88 (Schedule G, line 302, page 18 of the filing PDF)fewer than 6 (the count is not shown)
303Prezcobix tab 800 mg 3059676057530Listed by the FDA as Prezcobixdarunavir ethanolate and cobicistat800 mg; 150 mgtablet, film coatedJanssen Products, LP12,177.30 (Schedule G, line 303, page 18 of the filing PDF)10
304Mvasi SDV 100 mg/4 mL 155513020601Listed by the FDA as Mvasibevacizumab-awwb100 mg/4 mLinjection, solutionAmgen, Inc11,639.85 (Schedule G, line 304, page 18 of the filing PDF)92
305Rexulti 2 mg TABS59148003813Listed by the FDA as Rexultibrexpiprazole2 mgtabletOtsuka America Pharmaceutical, Inc.11,582.13 (Schedule G, line 305, page 18 of the filing PDF)17
306NovoLOG 100 units/mL SOLN00169750111Listed by the FDA as Novologinsulin aspart100 IU/mLinjection, solutionNovo Nordisk11,479.76 (Schedule G, line 306, page 18 of the filing PDF)75
307(no name printed)adalimumab-adbm (Cyltezo,CF, Pen) 40 mg/0.8 mL PnKt 0059703759711,159.72 (Schedule G, line 307, page 18 of the filing PDF)13
308Genvoya tab 3061958190101Listed by the FDA as Genvoyaelvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide150 mg; 150 mg; 200 mg; 10 mgtabletGilead Sciences, Inc.11,145.92 (Schedule G, line 308, page 18 of the filing PDF)fewer than 6 (the count is not shown)
309Exparel 1.3% SUSP65250026609Listed by the FDA as Exparelbupivacaine13.3 mg/mLinjection, suspension, liposomalPacira Pharmaceuticals, Inc.10,998.39 (Schedule G, line 309, page 18 of the filing PDF)48
310Kerendia TB 10 mg 3050419054001Listed by the FDA as Kerendiafinerenone10 mgtablet, film coatedBayer HealthCare Pharmaceuticals Inc.10,930.24 (Schedule G, line 310, page 18 of the filing PDF)29
311Revlimid 5 mg capsule59572040528Listed by the FDA as Revlimidlenalidomide5 mgcapsuleCelgene Corporation10,588.67 (Schedule G, line 311, page 18 of the filing PDF)13
312Gemtesa TB 75 mg 3073336007530Listed by the FDA as Gemtesavibegron75 mgtablet, film coatedSumitomo Pharma America, Inc.10,501.54 (Schedule G, line 312, page 18 of the filing PDF)56
313Zoladex PF syr 3.6 mg SNGL DS70720095036Listed by the FDA as Zoladexgoserelin3.6 mgimplantTerSera Therapeutics LLC10,415.29 (Schedule G, line 313, page 18 of the filing PDF)13
314MPB Xolair 150 mg/mL auto inj50242021555Listed by the FDA as Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc.10,356.21 (Schedule G, line 314, page 18 of the filing PDF)12
315Lantus Solostar 100 units/mL00088221905Listed by the FDA as Lantus Solostarinsulin glargine100 IU/mLinjection, solutionsanofi-aventis U.S. LLC10,335.03 (Schedule G, line 315, page 18 of the filing PDF)586
316glatiramer 40 mg/mL Syrg00378696112Listed by the FDA as Glatiramer Acetateglatiramer40 mg/mLinjection, solutionMylan Pharmaceuticals Inc.10,302.25 (Schedule G, line 316, page 18 of the filing PDF)14
317Abilify Maintena ER 300 mg kit59148023212Listed by the FDA as Abilify MaintenaaripiprazolekitOtsuka America Pharmaceutical, Inc.10,111.68 (Schedule G, line 317, page 18 of the filing PDF)7
318MPB Austedo 9 mg tab 6068546017160Listed by the FDA as Austedodeutetrabenazine9 mgtablet, coatedTeva Neuroscience, Inc.10,040.76 (Schedule G, line 318, page 18 of the filing PDF)fewer than 6 (the count is not shown)
319Caplyta 42 mg CAPS72060014240Listed by the FDA as Caplytalumateperone42 mgcapsuleIntra-Cellular Therapies, Inc9,948.89 (Schedule G, line 319, page 18 of the filing PDF)12
320Paxlovid standard dose 300/100 mg T00069504530Listed by the FDA as Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc9,608.60 (Schedule G, line 320, page 18 of the filing PDF)11
321Provocholine KIT64281011006Listed by the FDA as Provocholine Inhalation Solutionmethacholine chloride inhalation solutionkitMethapharm Inc.9,490.61 (Schedule G, line 321, page 18 of the filing PDF)75
322Dificid 200 mg TABS52015008001Listed by the FDA as Dificidfidaxomicin200 mgtablet, film coatedMerck Sharp & Dohme LLC9,483.82 (Schedule G, line 322, page 18 of the filing PDF)13
323AlbuRx 25% SOLN44206025110Listed by the FDA as AlbuRxalbumin (human)12.5 g/50 mLsolutionCSL Behring AG9,345.45 (Schedule G, line 323, page 18 of the filing PDF)157
324ferric carboxymaltose 750 mg/15 mL INJ00517065001Listed by the FDA as Injectaferferric carboxymaltose injection50 mg/mLinjection, solutionAmerican Regent, Inc.9,193.32 (Schedule G, line 324, page 19 of the filing PDF)25
325insulin aspart (NovoLOG Flexpen U-100 Insulin) 100 units/mL (3 mL) InPn00169633910Listed by the FDA as Novologinsulin aspart100 IU/mLinjection, solutionNovo Nordisk9,136.01 (Schedule G, line 325, page 19 of the filing PDF)134
326Yupelri Inhal sol175 mcg/3 mL 3049502080693Listed by the FDA as Yupelrirevefenacin175 mcg/3 mLsolutionViatris Specialty LLC9,110.93 (Schedule G, line 326, page 19 of the filing PDF)32
327Sofos/Velpa TB 400 mg/100 mg 2872626270101Listed by the FDA as Sofosbuvir and Velpatasvirvelpatasvir and sofosbuvir100 mg; 400 mgtablet, film coatedAsegua Therapeutics LLC9,033.63 (Schedule G, line 327, page 19 of the filing PDF)fewer than 6 (the count is not shown)
328Glucagon HCl (Diagnostic) 1 mg SOLR63323059303Listed by the FDA as GlucagonkitFresenius Kabi USA, LLC8,840.87 (Schedule G, line 328, page 19 of the filing PDF)81
329MPB Rituxan 500 mg/50 mL SDV50242005306Listed by the FDA as Rituxanrituximab10 mg/mLinjection, solutionGenentech, Inc.8,833.99 (Schedule G, line 329, page 19 of the filing PDF)fewer than 6 (the count is not shown)
330Acetaminophen 10 mg/mL SOLN24201010024Listed by the FDA as Acetaminophen10 mg/mLinjection, solutionHikma Pharmaceuticals USA Inc.8,507.32 (Schedule G, line 330, page 19 of the filing PDF)2,544
331Aimovig inj 140 mg/mL55513084301Listed by the FDA as Aimovigerenumab-aooe140 mg/mLinjection, solutionAmgen, Inc8,428.38 (Schedule G, line 331, page 19 of the filing PDF)68
332MPB Evenity 105 mg/1.17 mL PFS 255513099802Listed by the FDA as Evenityromosozumab-aqqg105 mg/1.17 mLinjection, solutionAmgen, Inc8,334.87 (Schedule G, line 332, page 19 of the filing PDF)fewer than 6 (the count is not shown)
333diazePAM 5 mg/mL SOLN00409127332Listed by the FDA as Diazepam5 mg/mLinjection, solutionHospira, Inc.8,131.07 (Schedule G, line 333, page 19 of the filing PDF)1,315
334Veozah tab 45 mg00469266030Listed by the FDA as Veozahfezolinetant45 mgtablet, film coatedAstellas Pharma US, Inc.7,925.27 (Schedule G, line 334, page 19 of the filing PDF)28
335EPINEPHrine 1 mg/10 mL SOSY76329331801Listed by the FDA as Epinephrine0.1 mg/mLinjectionInternational Medication Systems, Limited7,887.32 (Schedule G, line 335, page 19 of the filing PDF)324
336Budesonide/FORM 80/4.5 mcg (120 inh)00310737220Listed by the FDA as Budesonide and Formoterol Fumarate Dihydrate80 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP7,825.80 (Schedule G, line 336, page 19 of the filing PDF)93
337Symbicort 160-4.5 mcg inhaler00186037020Listed by the FDA as Symbicortbudesonide and formoterol fumarate dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP7,722.72 (Schedule G, line 337, page 19 of the filing PDF)130
338solriamfetoL (Sunosi) 150 mg Tab81968035101Listed by the FDA as Sunosisolriamfetol150 mgtablet, film coatedAxsome Therapeutics, Inc.7,521.47 (Schedule G, line 338, page 19 of the filing PDF)40
339Tremfya pen 200 mg/2 mL 257894065104Listed by the FDA as Tremfyaguselkumab200 mg/2 mLinjectionJanssen Biotech, Inc.7,507.70 (Schedule G, line 339, page 19 of the filing PDF)fewer than 6 (the count is not shown)
340Truxima SDV 500 mg/50 mL 163459010450Listed by the FDA as Truximarituximab-abbs10 mg/mLinjection, solutionCephalon, Inc.7,476.63 (Schedule G, line 340, page 19 of the filing PDF)7
341Tyenne PFS 162 mg/0.9 mL 165219058604Listed by the FDA as Tyennetocilizumab-aazg162 mg/0.9 mLinjection, solutionFresenius Kabi USA, LLC7,355.54 (Schedule G, line 341, page 19 of the filing PDF)18
342Zoryve crm 0.3% 60 g80610013060Listed by the FDA as Zoryveroflumilast3 mg/gcreamArcutis Biotherapeutics, Inc.7,330.84 (Schedule G, line 342, page 19 of the filing PDF)13
343Ajovy Autoinject 225 mg/1.5 mL 151759020210Listed by the FDA as Ajovyfremanezumab-vfrm225 mg/1.5 mLinjectionTeva Pharmaceuticals USA, Inc.7,191.78 (Schedule G, line 343, page 19 of the filing PDF)42
344Qulipta 30 mg tablets00074709630Listed by the FDA as Quliptaatogepant30 mgtabletAbbVie Inc.7,185.34 (Schedule G, line 344, page 19 of the filing PDF)20
345Retacrit 10,000 units/mL SOLN00069130810Listed by the FDA as Retacritepoetin alfa-epbx10,000 IU/mLinjection, solutionPfizer Laboratories Div Pfizer Inc7,101.84 (Schedule G, line 345, page 19 of the filing PDF)87
346Vascepa cap 1 g52937000120Listed by the FDA as Vascepaicosapent ethyl1,000 mgcapsuleAmarin Pharma Inc.7,076.80 (Schedule G, line 346, page 19 of the filing PDF)16
347Sublocade 100 mg/0.5 mL Syring12496010001Listed by the FDA as Sublocadebuprenorphine100 mgsolutionIndivior Inc.7,006.67 (Schedule G, line 347, page 19 of the filing PDF)fewer than 6 (the count is not shown)
348Cinvanti inj SDV 130 mg/18 mL 147426020101Listed by the FDA as Cinvantiaprepitant130 mg/18 mLinjection, emulsionHeron Therapeutics, Inc.6,980.75 (Schedule G, line 348, page 19 of the filing PDF)53
349ceFAZolin Sodium 1 g SOLR00143992490Listed by the FDA as Cefazolin330 mg/mLinjection, powder, for solutionHikma Pharmaceuticals USA Inc.6,973.80 (Schedule G, line 349, page 19 of the filing PDF)6,748
350Vraylar cap 4.5 mg 3061874014530Listed by the FDA as Vraylarcariprazine4.5 mgcapsule, gelatin coatedAllergan, Inc.6,894.24 (Schedule G, line 350, page 19 of the filing PDF)9
351Admelog SoloStar 100 units/mL SOPN00024592505Listed by the FDA as Admeloginsulin lispro100 units/mLinjection, solutionSanofi-Aventis U.S. LLC6,864.21 (Schedule G, line 351, page 19 of the filing PDF)fewer than 6 (the count is not shown)
352Plaquenil tab 200 mg59212056210Listed by the FDA as Plaquenilhydroxychloroquine sulfate200 mgtabletAdvanz Pharma (US) Corp.6,766.56 (Schedule G, line 352, page 19 of the filing PDF)fewer than 6 (the count is not shown)
353Vancomycin HCl 2,000 mg/400 mL SOLN70594004402Listed by the FDA as Vancomycin2 g/400 mLinjection, solutionXellia Pharmaceuticals USA LLC6,662.42 (Schedule G, line 353, page 19 of the filing PDF)419
354Ventolin HFA 108 (90 Base) mcg/ACT AERS00173068224Listed by the FDA as Ventolin HFAalbuterol sulfate90 mcgaerosol, meteredGlaxoSmithKline LLC6,423.57 (Schedule G, line 354, page 19 of the filing PDF)1,024
355MPB Pemgarda 500 mg/4 mL 9 DS81960003103Listed by the FDA as Pemgardapemivibart125 mg/mLinjectionInvivyd, Inc6,350.00 (Schedule G, line 355, page 19 of the filing PDF)fewer than 6 (the count is not shown)
356Sincalide 5 mcg SOLR72266024805Listed by the FDA as Sincalide5 mcg/5 mLinjection, powder, lyophilized, for solutionFosun Pharma USA Inc6,336.67 (Schedule G, line 356, page 19 of the filing PDF)98
357PHENobarbital Sodium 130 mg/mL SOLN00641047725Listed by the FDA as Phenobarbital Sodium130 mg/mLinjectionHikma Pharmaceuticals USA Inc.6,281.50 (Schedule G, line 357, page 19 of the filing PDF)96
358Myfembree TB 40/1/0.5 mg 2872974041501Listed by the FDA as Myfembreerelugolix, estradiol hemihydrate, and norethindrone acetate40 mg; 1 mg; 0.5 mgtablet, film coatedSumitomo Pharma America, Inc6,210.60 (Schedule G, line 358, page 19 of the filing PDF)11
359Elitek 1.5 mg SOLR00024515010Listed by the FDA as ElitekrasburicasekitSanofi-Aventis U.S. LLC6,203.74 (Schedule G, line 359, page 19 of the filing PDF)fewer than 6 (the count is not shown)
360Admelog 100 units/mL SOLN00024592605Listed by the FDA as Admeloginsulin lispro100 units/mLinjection, solutionSanofi-Aventis U.S. LLC6,142.50 (Schedule G, line 360, page 19 of the filing PDF)1,510
361MPB Darzalex 100 mg/5 mL SDV57894050505Listed by the FDA as Darzalex IVdaratumumab100 mg/5 mLinjection, solution, concentrateJanssen Biotech, Inc.6,127.96 (Schedule G, line 361, page 19 of the filing PDF)14
362MPB Onivyde 43 mg/10 mL SDV15054004301Listed by the FDA as Onivydeirinotecan hydrochloride4.3 mg/mLinjection, powder, for solutionIpsen Biopharmaceuticals, Inc.6,047.44 (Schedule G, line 362, page 20 of the filing PDF)fewer than 6 (the count is not shown)
363Lisdexamf DIM CP 70 mg ALV 100@47781056801Listed by the FDA as Lisdexamfetamine Dimesylate70 mgcapsuleAlvogen Inc.6,029.76 (Schedule G, line 363, page 20 of the filing PDF)16
364Feraheme vial 510 mg 17 mL 159338077501Listed by the FDA as Ferahemeferumoxytol510 mg/17 mLinjectionAMAG Pharmaceuticals, Inc6,019.56 (Schedule G, line 364, page 20 of the filing PDF)53
365Kinevac vial 5 mcg 1000270055615Listed by the FDA as Kinevacsincalide5 mcg/5 mLinjection, powder, lyophilized, for solutionBracco Diagnostics Inc.5,996.20 (Schedule G, line 365, page 20 of the filing PDF)fewer than 6 (the count is not shown)
366Furosemide 10 mg/mL SOLN00409610210Listed by the FDA as Furosemide10 mg/mLinjection, solutionHospira, Inc.5,931.54 (Schedule G, line 366, page 20 of the filing PDF)1,281
367Cimzia pre filled syr 2x200 mg50474071079Listed by the FDA as Cimziacertolizumab pegol200 mg/mLinjection, solutionUCB, Inc.5,890.27 (Schedule G, line 367, page 20 of the filing PDF)93
368ProvayBlue 50 mg/10 mL SOLN00517037405Listed by the FDA as Provaybluemethylene blue5 mg/mLinjectionAmerican Regent, Inc.5,827.09 (Schedule G, line 368, page 20 of the filing PDF)81
369Liletta (52 mg) 20.1 mcg/DAY IUD00023585801Listed by the FDA as Lilettalevonorgestrel52 mgintrauterine deviceAllergan, Inc.5,717.59 (Schedule G, line 369, page 20 of the filing PDF)18
370MPB Xolair 75 mg/0.5 mL auto inj50242021455Listed by the FDA as Xolair PFSomalizumab75 mg/0.5 mLinjection, solutionGenentech, Inc.5,681.46 (Schedule G, line 370, page 20 of the filing PDF)13
371PHENobarbital Sodium 130 mg/mL SOLN54288013710Listed by the FDA as Phenobarbital Sodium130 mg/mLinjectionBPI Labs LLC5,679.52 (Schedule G, line 371, page 20 of the filing PDF)42
372Copaxone 40 mg pref syr 1268546032512Listed by the FDA as Copaxoneglatiramer acetate40 mg/mLinjection, solutionTeva Neuroscience, Inc.5,630.09 (Schedule G, line 372, page 20 of the filing PDF)fewer than 6 (the count is not shown)
373MPB Tecentriq 840 mg/14 mL SDV50242091801Listed by the FDA as Tecentriqatezolizumab840 mg/14 mLinjection, solutionGenentech, Inc.5,556.49 (Schedule G, line 373, page 20 of the filing PDF)fewer than 6 (the count is not shown)
374Praluent 75 mg/mL pen61755002002Listed by the FDA as Praluentalirocumab75 mg/mLinjection, solutionRegeneron Pharmaceuticals, Inc.5,552.53 (Schedule G, line 374, page 20 of the filing PDF)161
375Invega Sustenna 117 mg kit50458056201Listed by the FDA as Invega Sustennapaliperidone palmitate117 mg/0.75 mLinjectionJanssen Pharmaceuticals, Inc.5,538.05 (Schedule G, line 375, page 20 of the filing PDF)9
376MPB Qutenza 8% 179 mg patch 472512093001Listed by the FDA as QutenzacapsaicinkitAveritas Pharma Inc5,457.25 (Schedule G, line 376, page 20 of the filing PDF)fewer than 6 (the count is not shown)
377Lupron Depot 22.5 mg KT 3346-0300074334603Listed by the FDA as Lupron Depotleuprolide acetatekitAbbVie Inc.5,353.70 (Schedule G, line 377, page 20 of the filing PDF)18
378Bimzelx 320 mg/2 mL PFS kit50474078378Listed by the FDA as Bimzelxbimekizumab320 mg/2 mLinjection, solutionUCB, Inc.5,327.36 (Schedule G, line 378, page 20 of the filing PDF)fewer than 6 (the count is not shown)
379upadacitinib (Rinvoq) 45 mg Tb2400074104328Listed by the FDA as Rinvoqupadacitinib45 mgtablet, extended releaseAbbVie Inc.5,276.29 (Schedule G, line 379, page 20 of the filing PDF)fewer than 6 (the count is not shown)
380Gvoke HypoPen 2-pack 1 mg/0.2 mL72065012112Listed by the FDA as Gvoke HypoPen 1 mg Auto-Injectorglucagon injection, solution1 mg/0.2 mLinjection, solutionXeris Pharmaceuticals, Inc.5,272.83 (Schedule G, line 380, page 20 of the filing PDF)15
381Emerphed 5 mg/mL SOLN14789025010Listed by the FDA as Emerphedephedrine sulfate5 mg/mLinjectionNexus Pharamaceuticals Inc.5,200.59 (Schedule G, line 381, page 20 of the filing PDF)743
382Ketorolac Tromethamine 30 mg/mL SOLN63323016201Listed by the FDA as Ketorolac Tromethamine30 mg/mLinjection, solutionFresenius Kabi USA, LLC5,196.11 (Schedule G, line 382, page 20 of the filing PDF)5,762
383Albutero Sul HFA90 mcg PRAS18 g@66993001968Listed by the FDA as Albuterol Sulfate HFA90 mcgaerosol, meteredPrasco Laboratories5,169.08 (Schedule G, line 383, page 20 of the filing PDF)261
384ramucirumab 100 mg/10 mL INJ00002766901Listed by the FDA as Cyramzaramucirumab10 mg/mLsolutionEli Lilly and Company5,082.86 (Schedule G, line 384, page 20 of the filing PDF)fewer than 6 (the count is not shown)
385Biktarvy tab 50/200/25 mg 3061958250101Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc.5,024.30 (Schedule G, line 385, page 20 of the filing PDF)fewer than 6 (the count is not shown)
386Praluent2x150 mg Prefilled pens61755002102Listed by the FDA as Praluentalirocumab150 mg/mLinjection, solutionRegeneron Pharmaceuticals, Inc.5,020.76 (Schedule G, line 386, page 20 of the filing PDF)23
387Acetylcysteine 200 mg/mL SOLN55150025930Listed by the FDA as Acetylcysteine6 g/30 mLinjection, solutionEugia US LLC5,020.50 (Schedule G, line 387, page 20 of the filing PDF)117
Total Prescription Drugs individually under $5,0002,341,457.11 (Schedule G, row for amounts under $5,000, page 20 of the filing PDF)257,621 (Schedule G, claims on the row for amounts under $5,000, page 20 of the filing PDF)
Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement44,095,350.32 (Schedule G, printed total, page 20 of the filing PDF)332,510 (Schedule G, printed claims total, page 20 of the filing PDF)

What “fewer than 6” means. A count of 1 to 5 is not shown on this site or in its data files. Methods, section 9, says how.

Amounts and counts are the filer’s own, in US dollars. They are written here with commas between thousands, and an amount filed with one decimal place is written with two. No value is changed: the filing and the download keep each figure as typed.

Drug names are the filer’s own words. Filers type them in many ways, so this page writes them one way: capitals, spaces, unit names such as mg and mL, a zero before a decimal point, and commas in long numbers. No word is changed, spelled out or left out, and shorthand stays as the filer typed it. The filing and the download keep each name as typed, and a search here reads both.

“Listed by the FDA as” is not part of the filing. It is the name, ingredient, strength, form and labeler that the U.S. Food and Drug Administration’s National Drug Code Directory lists for the row’s code, as downloaded on 11 November 2026. 381 of the 387 rows have one. A row has none when its code is not filed as one 11-digit code or the directory has never listed it. Where the directory has since dropped a code, the name is kept as it was last listed, and the line says so. The directory’s capitals, strengths and unit names are written one way on this page. How a code is matched

Source

Filing PDF
Open Schedule G on the State of Rhode Island's website
SHA-256
4c51e84a5a25f096f4e626d8e7c794404bee305d5f2be7d453642a696448d20e
Retrieved
11 November 2026
Pages used
10 to 20 of 22